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Abstract
Background: Depression is more common in obese than non-obese individuals, espe-
cially in women, but the causal relationship between obesity and depression is complex
and uncertain. Previous studies have used genetic variants associated with BMI to pro-
vide evidence that higher body mass index (BMI) causes depression, but have not tested
whether this relationship is driven by the metabolic consequences of BMI nor for differ-
ences between men and women.
Methods: We performed a Mendelian randomization study using 48 791 individuals with
depression and 291 995 controls in the UK Biobank, to test for causal effects of higher BMI
on depression (defined using self-report and Hospital Episode data). We used two genetic
instruments, both representing higher BMI, but one with and one without its adverse meta-
bolic consequences, in an attempt to ‘uncouple’ the psychological component of obesity
from the metabolic consequences. We further tested causal relationships in men and
women separately, and using subsets of BMI variants from known physiological pathways.
Results: Higher BMI was strongly associated with higher odds of depression, especially in
women. Mendelian randomization provided evidence that higher BMI partly causes de-
pression. Using a 73-variant BMI genetic risk score, a genetically determined one standard
deviation (1 SD) higher BMI (4.9 kg/m2) was associated with higher odds of depression in
all individuals [odds ratio (OR): 1.18, 95% confidence interval (CI): 1.09, 1.28, P¼0.00007)
and women only (OR: 1.24, 95% CI: 1.11, 1.39, P¼0.0001). Meta-analysis with 45 591
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depression cases and 97 647 controls from the Psychiatric Genomics Consortium (PGC)
strengthened the statistical confidence of the findings in all individuals. Similar effect size
estimates were obtained using different Mendelian randomization methods, although not
all reached P< 0.05. Using a metabolically favourable adiposity genetic risk score, and
meta-analysing data from the UK biobank and PGC, a genetically determined 1 SD higher
BMI (4.9 kg/m2) was associated with higher odds of depression in all individuals (OR: 1.26,
95% CI: 1.06, 1.50], P¼0.010), but with weaker statistical confidence.
Conclusions: Higher BMI, with and without its adverse metabolic consequences, is likely
to have a causal role in determining the likelihood of an individual developing depression.
Key words: Body mass index, depression, Mendelian randomization, UK Biobank
Introduction
Obesity and depression are two global health problems,
that are estimated to cost the global economy trillions of
dollars per annum.1,2 Higher body mass index (BMI) is ob-
servationally associated with higher odds of depression.3,4
These associations tend to be stronger in women than men,
with a U-shaped relationship often observed in men.5,6 It is
important to understand whether obesity causes depres-
sion, to optimize public health and medical intervention
planning. Weight loss is difficult to achieve and maintain,
and even more so for people with depression.7,8 There is
much debate within the literature about the directionality
of the relationship between obesity and depression, with
conflicting evidence from different studies including meta-
analyses and prospective data. These studies include those
suggesting that: (i) obesity causes depression;9 (ii) depres-
sion causes obesity;10 or (iii) there is a reciprocal link be-
tween the two.11 However, determining causality is not
trivial, especially when most observational associations
will be confounded or biased.
A genetic approach, Mendelian randomization (MR)
(Figure 1), can be used to test for a causal relationship be-
tween higher BMI and depression. Genetic variants
associated with BMI can act as unconfounded proxies be-
cause inherited genetic variation is randomly allocated at
conception. A number of studies have used this method to
investigate if BMI causally influences depression. These
studies were limited by either relatively small sample sizes
for MR, or by a reliance on summary statistics from large
genome-wide association study (GWAS) consortia. The re-
liance on summary statistics from GWAS means that strati-
fied analyses, for example by sex, are not possible.
Previous studies include those using the FTO variant12 and
a 32-single nucleotide polymorphism (SNP) BMI genetic
risk score (GRS).13 Two more recent studies used statistics
from up to 90 variants associated with BMI and the most
recent GWAS studies of depression. These studies included
9240 cases and 9519 controls14 and 135 458 cases and
344 901 controls, respectively,15 and provided further evi-
dence for the causal role of BMI in depression. However,
these previous studies were not able to answer more de-
tailed questions about the potential causal relationship be-
tween BMI and depression. First, no studies have used
genetics to test the causal role of BMI in men and women
separately, an important consideration given the different
observational associations and well-known social and
Key Messages
• This study provides evidence for the causal role of high BMI in depression, using individual-level data from the UK
Biobank and summary statistics from the Psychiatric Genomics Consortium. It represents the largest set of data used
to address this question.
• Using genetic variants associated with high BMI but a favourable metabolic profile, we demonstrate evidence for a
causal relationship between high BMI and depression in the absence of adverse metabolic effects.
• The availability of individual-level statistics from the UK Biobank enabled us to compare the relationship in males
and females separately.
• Negative control Mendelian randomization tests were also performed to explore the potential for residual confound-
ing in the data.
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cultural differences of body image between men and
women.16,17 These differences include those at the ends of
the BMI spectrum, with very thin men more likely to be de-
pressed than normal weight men and very thin women
(creating a U-shaped relationship in men5 possibly due to
illness). Second, MR studies to date have not explored the
hypothesis that obesity, or the perception of body size, in
childhood could influence depression in later life. Finally,
previous studies have not attempted to uncouple the poten-
tial psychological aspects of the BMI-depression relation-
ship from physiological aspects—something that is very
difficult to do without a genetic approach. Previous studies
have suggested that physiological as well as psychological
factors could cause depression—for example poorer over-
all health and adverse metabolic factors such as
inflammation.18,19
Here, we used Mendelian randomization to test the hy-
pothesis that causal pathways link BMI to higher odds of
depression and explore the role of both metabolic and psy-
chological components of obesity. We used data from the
UK Biobank, starting from 451 099 individuals of
European ancestry, of whom we classified 340 786 as ei-
ther a depression case or control. We used two genetic
instruments, both representing higher BMI, but one with
and one without its adverse metabolic consequences, in an
attempt to ‘uncouple’ the psychological component of obe-
sity from the metabolic consequences (metabolically
‘unfavourable’ and ‘favourable’ adiposity20). We tested
effects in men and women separately, used a subset of
BMI-associated variants to test effects more likely to be
specific to neuronal pathways and examined the relation-
ship between perceived childhood size and depression.
Methods
UK Biobank
The UK Biobank is a study of 500 000 individuals aged be-
tween 37 and 73 years (with 99.5% between 40 and
69 years), recruited from across the UK in 2006–10. The
study is described in detail elsewhere.21 Briefly,
participants provided a range of information via question-
naires and interviews (e.g. demographics, health status),
anthropometric measures and blood pressure readings;
blood, urine and saliva samples were taken for future
analysis, and participants agreed to have their health fol-
lowed over time via hospital record linkage and follow-
ups. Genetics were available for all individuals. SNP
genotypes were generated from the Affymetrix Axiom UK
Biobank array (450 000 individuals) and the UKBiLEVE
array (50 000 individuals). This dataset underwent ex-
tensive central quality control [http://biobank.ctsu.ox.ac.
uk]. We based our study on 451 099 individuals of White
European descent, as defined by principal components
analysis (PCA). Briefly, principal components were gener-
ated in the 1000 Genomes Cohort using high-confidence
SNPs to obtain their individual loadings. These loadings
were then used to project all of the UK Biobank samples
into the same principal component space, and individuals
were then clustered using principal components 1 to 4.
Participants were removed if they had subsequently with-
drawn from the study (n¼ 7) or if they were sex mis-
matches (n¼348; self-reported sex did not match genetic
sex). We also used a subset of unrelated individuals
(n¼ 379 768). The unrelated individuals were defined
from the 451 099 individuals of White European descent,
and the KING Kinship matrix was used to separate out re-
lated individuals (up to third degree). An optimal list of
unrelated individuals was generated to allow maximum
numbers of individuals to be included. Ancestral principal
components were then generated within these identified
individuals for use in subsequent analyses.
Patient involvement
This study was conducted using the UK Biobank resource,
which has details on patient and public involvement avail-
able online at [http://www.ukbiobank.ac.uk/about-biobank-
uk/] and [https://www.ukbiobank.ac.uk/wp-content/uploads/
2011/07/Summary-EGF-consultation.pdf?phpMyAdmin=trm
KQlYdjjnQIgJ%2CfAzikMhEnx6]. No patients were spe-
cifically involved in setting the research question or the
Figure 1. The principles of Mendelian randomization and key MR assumptions which are: (i) the genetic instrument (Z) is robustly related to the risk
factor of interest (X); (ii) Z is not associated with confounders (C) of the X-outcome (Y) association; and (iii) there is no path from Z to Y other than
through X (part a). Part b shows how this may be violated.
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outcome measures, nor were they involved in developing
plans for recruitment, design or implementation of this
study. No patients were asked to advise on interpretation
or writing up of results. There are no specific plans to dis-
seminate the results of the research to study participants,
but the UK Biobank disseminates key findings from proj-
ects on its website.
Exposure and outcome measures
In this study, we investigated the causal role of BMI on
depression; BMI is therefore the exposure and depression
is the outcome. We used genetic instruments to investigate
the role of higher BMI on depression, with and without its
adverse effects, including inflammation, insulin resistance
and metabolic diseases such as type 2 diabetes, hyperten-
sion and coronary artery disease.
Body mass index
BMI was calculated for all participants from measured
weight (kg)/height (m)2. BMI was available for 340 786
individuals with genetic data available, whom we classified
as depression cases or controls. BMI was inverse-
normalized before analysis. The BMI variable was vali-
dated and demonstrated to associate with known demo-
graphics including age, sex, socioeconomic position and
type 2 diabetes status (Supplementary Table 1, available as
Supplementary data at IJE online). We also created a bi-
nary obesity variable where we classified individuals as
normal BMI (measured BMI between 18.5 and 24.9 kg/m2)
and obese individuals (BMI greater than 30 kg/m2).
Depression
The main depression measure used in these analyses com-
bined data from the self-report questionnaire in UK
Biobank and the Hospital Episode Statistic data.
Individuals were considered a case if they met one or more
of the following criteria:
• self-reported seeing a GP for nerves/anxiety or depres-
sion AND reported at least a 2-week duration of depres-
sion or unenthusiasm;
• self-reported seeing a psychiatrist for nerves/anxiety or
depression AND reported at least a 2-week duration of
depression or unenthusiasm;
• had the following ICD-10 codes in the Hospital Episode
Statistics: F33 representing recurrent major depressive dis-
order (MDD) or F32 representing single-episode MDD.
By combining these criteria, we had 48 791 cases
(41 397 in the analyses of unrelated participants) with a
valid BMI measure (Figure 2).
Controls were defined as individuals not reporting ever vis-
iting a GP or psychiatrist for nerves/anxiety or self-reporting
depression in the non-cancer illness variable in the UK
Biobank and not having an ICD-10 code relating to MDD.
This resulted in 291 995 controls (246 106 in unrelated) with
a valid BMI measure. Basic characteristics of the cases and
controls are described in Table 1 and in Supplementary Table
2, available as Supplementary data at IJE online.
In this case-control analysis, we used participants who
did not have any indication for history of depression as the
control group, and excluded participants with unclear sta-
tus and/or likely mild depression. Of these 110 000
Figure 2. Flow chart explaining the derivation of depression cases and controls in the UK Biobank.
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individuals who were neither included in depression case
nor in control group, 35% were men, 12% were smokers
and 8% identified themselves as ‘non-drinkers’. Around
13% of these individuals reported that they had had a doc-
tor-diagnosed depression. Nearly all (99.7%) had seen a
GP or psychiatrist for depression, anxiety, nervousness or
tension, but either had not experienced prolonged periods
of depression and/or unenthusiasm (8%) or had this infor-
mation missing (92%).
A number of more stringent measures were considered
in sensitivity analyses, with the depression measure further
characterized as: (i) single episode; or (ii) recurrent, based
on the classification in the ICD-10 code data and/or using
the self-reported number of occurrences variable in the UK
Biobank. Finally, a depression measure that only used the
HES data was also considered.
Observational associations
We regressed depression status against BMI using logistic
regression models. We adjusted these for age, sex and as-
sessment centre. Models were then further adjusted for a
measure of socioeconomic position (using the Townsend
deprivation index), smoking, alcohol consumption and
physical activity measures (using data from the interna-
tional physical activity questionnaire). Similar analyses
were conducted for self-perceived weight status at age
10 years, with further adjustment for adult BMI.
Genetic variants
We selected genetic variants from UK Biobank’s imputa-
tion dataset. Variants were excluded if the genotype proba-
bility was <0.9. Details of the imputation quality are given
in Supplementary Table 3, available as Supplementary
data at IJE online.
Genetic variants associated with BMI
We selected 73 of 76 common genetic variants that were
associated with BMI at genome-wide significance in the
GIANT consortium in studies of up to 339 224 people
(Supplementary Table 3, available as Supplementary data
at IJE online).22 We limited the BMI variants to those that
were associated with BMI in the analysis of all people of
European ancestry, and did not include those that reached
genome-wide levels of statistical confidence in only one sex
or one stratum. We also excluded variants if they were
known to be classified as a secondary signal within a locus.
In the primary analysis, three variants were excluded from
the score because they were known to have pleiotropic
effects on other traits [rs11030104 (BDNF reward pheno-
types including smoking), rs13107325 (SLC39A8 lipids,
blood pressure), rs3888190 (SH2B1 multiple traits)].
These three variants were defined as pleiotropic because
they had larger effects on a third trait than their effects on
BMI, meaning they are very likely acting on non-BMI re-
lated pathways. We repeated the MR tests with these three
variants back in as a sensitivity analysis.
Neuronal and non-neuronal BMI genetic instruments
The 73 BMI SNPs were further separated into two sub-
groups—a neuronal and a non-neuronal group, based on
their presence in or near genes enriched in specific path-
ways as summarized in Supplementary Table 3 of the
Locke et al., 2015 paper22 (Supplementary Table 3, avail-
able as Supplementary data at IJE online). The neuronal
group included 43 SNPs implicated in either neuronal de-
velopment, neuronal expression, neurotransmission and/or
hypothalamic expression pathways. The remaining 30
BMI SNPs had not been implicated in the above pathways
and were categorized into the non-neuronal group.
Favourable adiposity genetic variants
We selected 14 common variants (Supplementary Table 3,
available as Supplementary data at IJE online) that were
associated with higher body fat percentage, but lower risk
of metabolic disease.20,23 The 14 variants explained 0.2%
of the variance in BMI in the UK Biobank participants.
These variants were defined as follows. We performed a
genome-wide association study of body fat percentage, as
measured by impedance, in the UK Biobank. In parallel we
performed a multivariate genome-wide association study
of seven traits using summary statistics from published
GWAS—body fat percentage,24 high-density lipoprotein
(HDL) cholesterol,25 triglycerides,25 sex hormone binding
globulin,26 adiponectin,27 fasting insulin28 and alanine
aminotransferase (ALT).29 Cross-tabulation of the variants
associated with body fat percentage and the variants asso-
ciated with the multivariate outcome revealed 33 variants
associated with multiple metabolic outcomes. A cluster
analysis of these 33 variants revealed 14 that clustered to-
gether because alleles associated with higher body fat per-
centage were associated with a favourable metabolic
profile of the other six markers (e.g. the allele associated
with higher body fat percentage was associated with higher
HDL cholesterol and lower triglycerides).
Individual variants were recoded as 0, 1 and 2, accord-
ing to the number of adult BMI or favourable adiposity in-
creasing alleles. Weighted GRS were created using the
adult BMI and favourable adiposity. Each variant was
weighted by its effect size (b-coefficient) obtained from the
primary GWAS that did not include any data from the UK
Biobank.20,22 The weighted score was rescaled to reflect
the number of trait-increasing alleles (Equation 2).
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Weighted score ¼ b1 x SNP1 þ b2 x SNP2
þ   bn x SNPn
(Equation 1)
Weighted genetic risk score ¼ weighted score x number of SNPs
sum of the b coefficients
(Equation 2)
Mendelian randomization
We used Mendelian randomization to investigate causal
pathways between BMI and depression. Mendelian random-
ization relies on several assumptions as outlined below:30
• the BMI and favourable adiposity genetic risk scores are
robustly associated with measured BMI;
• the BMI and favourable adiposity genetic risk scores are
not associated, independently of their effects on BMI,
with confounding factors that bias conventional epide-
miological associations between depression and obesity.
In this study, we employed several Mendelian
sandomization approaches, first the standard one-sample in-
strumental variable analyses using the genetic risk scores in
the unrelated data set of 287 503 individuals. Second, we in-
vestigated the causal relationship using a two-sample ap-
proach in both the unrelated (n¼287 503) and related
(n¼ 340 786) individuals. In this step, we tested if our results
were robust to any potential influence of population stratifica-
tion by using linear mixed models approach as implemented
in the software BOLT-LMM (version 2.331). This approach
corrects for all levels of interindividual correlation of geno-
types due to relatedness, from close to distant relatives.
One-sample Mendelian randomization: instrumental
variable analysis
We employed the two-stage least-squares regression esti-
mator method that uses predicted levels of BMI per geno-
type and regresses the depression outcome against these
predicted values. The instrumental variable analysis was
performed in two stages, as all our outcomes were binary.
First, we assessed the association between the BMI or
favourable adiposity GRS and BMI. The predicted values
and residuals from this regression model were saved.
Second, the predicted values from stage 1 were used as the
independent variable (reflecting an unconfounded estimate
of variation in BMI) and depression as the dependent vari-
able in a logistic regression model. Robust standard errors
were used to correct for the uncertainty in the estimate.
Two-sample Mendelian randomization approaches
We also employed a two-sample MR approach to analyse
results in the larger dataset corrected for relatedness using
BOLT-LMM. The depression outcome was run through
BOLT-LMM as a genome-wide association scan. The BMI
and favourable adiposity genetic variants were then
extracted. We performed inverse variance weighted (IVW)
instrumental variable analysis and two methods that are
more robust to the potential violations of the standard in-
strumental variable assumptions (MR-Egger32 and Median
MR33) The two-sample approach regresses the effect sizes
of variant-outcome associations (here BMI or favourable
adiposity variants versus depression) against effect sizes of
the variant-risk factor associations (here BMI or favour-
able adiposity variants versus BMI). The variant-risk factor
associations were taken from the primary GWAS of BMI22
and from the primary GWAS of body fat percentage for
the 14 favourable adiposity variants.20,24 We also
extracted association statistics for the 73 BMI and 14
favourable adiposity variants from the recent GWAS of de-
pression by the Psychiatric Genomics Consortium (PGC;
Supplementary material, available as Supplementary data
at IJE online) to replicate our two-sample MR analyses in
an independent sample of 45 591 depression cases and
97 647 controls, which excluded the UK Biobank samples
and 23&Me samples from the primary PGC analyses.15
The IVW approach assumes that there is no horizontal
pleiotropy (under a fixed effect model) or, if implemented
under a random effects model after detecting heterogeneity
among the causal estimates, that:
• the strength of the association of the genetic instruments
with the risk factor is not correlated with the magnitude
of the pleiotropic effects; and
• the pleiotropic effects have an average value of zero.
The MR-Egger uses a weighted regression with an uncon-
strained intercept to remove the assumption that all genetic
variants are valid instrumental variables, and is therefore
less susceptible to confounding from potentially pleiotropic
variants that have a stronger effect on the outcome com-
pared with their effect on the primary traits. The Median-
MR method takes the median instrumental variable from all
variants included, and is robust when up to (but not includ-
ing) 50% of the genetic variants are invalid. Given these dif-
ferent assumptions, if all methods are broadly consistent this
strengthens our causal inference. Details of the R code for
the two-sample IVW, MR-Egger and Median-MR analyses
are provided in Bowden et al., 2015 and 2016.33,34
Assuming that both neuronal and non-neuronal genetic
risk scores instrumented the same exposure, BMI, we used
an over-identification test35 to check whether the causal
estimates from these two genetic risk scores were consis-
tent (i.e. both of the GRS are valid genetic instruments).
Rejecting this hypothesis may indicate the effect of genetic
risk score on depression through a mechanism other than
through BMI. For this particular analysis, we used
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‘ivprobit’ command- based two-stage regression followed
by an over-identification test (using ‘overid’ Stata
command).
Differences between men and women
To test the hypothesis that the effects of BMI on depression
may differ in males and females, we repeated observational
and genetic analyses separately in each sex. The selected
BMI and favourable adiposity genetic variants have very
similar effects in men and women, and therefore the same
genetic variants and risk scores were used in all partici-
pants, in males only and in females only. The beta values
for males and females were compared using Fisher’s
z-score method (Equation 3).36
z ¼ b1  b2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE1
2 þ SE22
p
Sensitivity analysis
We performed six sensitivity analyses. We repeated our analy-
sis, first using more stringent measures of depression by:
(i) further categorizing the depression into single-episode de-
pression and recurrent depression, using the number of de-
pression episodes in UK Biobank; (ii) restricting individuals to
those with a Hospital Episode Statistic (HES) record, of
whom 10 939 had a primary or secondary ICD-10 code of
single-episode or recurrent MDD (F32 and F33, respectively;
95% reported as a secondary diagnosis); and (iii) using the
mental health questionnaire data available in 124 282, where
participants were asked ‘Have you been diagnosed with de-
pression by a professional, even if you don’t have it
currently?’. Second, we repeated our analysis restricting to
individuals self-reporting no other health problems [including
cancers and non-cancer (e.g. type 2 diabetes and coronary ar-
tery disease) illnesses at baseline]. Third, we repeated our
analysis excluding individuals reporting a family history of
depression, as this was strongly associated with depression in
our participants (OR: 2.74, 95% CI: 2.64, 2.82). Fourth, we
repeated the analysis by excluding underweight (BMI<18.5
kg/m2) individuals. Finally, we repeated the primary MR test
in all individuals with a 76 BMI SNP instrument that in-
cluded the three variants we defined as pleiotropic.
Further tests to minimize the potential influence of
pleiotropy
To objectively identify and exclude variants with potential
pleiotropic effects, we tested the association of each BMI
variant and each favourable adiposity variant against the de-
pression measure. Variants with larger effects on the outcome
than the exposure are unlikely to be specific instruments for
the exposure. The odds ratio estimates were converted to
standard deviation effect sizes and compared with the pri-
mary trait effect size for the variant (Supplementary Table 4,
available as Supplementary data at IJE online).37 No SNPs
were excluded based on these analyses.
Childhood BMI and depression later in life
Using a self-reported perceived body weight at age 10, we
also investigated the influence of childhood BMI on depres-
sion later in life. The self-reported perceived body weight at
age 10 was derived from the following question: ‘When you
were 10 years old, compared to average would you describe
yourself as:’, with the options: ‘Thinner’, ‘Plumper’, ‘About
average’, ‘Prefer not to answer’ or ‘Don’t know’. The obser-
vational association between self-perceived weight status at
age 10 and depression was adjusted for adult BMI.
Negative control tests
We also tested the validity of the Mendelian randomization
approaches by performing a number of negative control
experiments. These tests included looking at the observa-
tional and genetic BMI associations with: i) sun protection
use; (ii) nitrogen dioxide pollution levels; and (iii) urban or
rural home dwelling. These measures are strongly observa-
tionally associated with BMI, but BMI causing changes in
sun protection use, nitrogen dioxide pollution levels or
home location is less plausible.
Results
The demographics of the 340 786 UK Biobank individuals
with valid genetic data, BMI and whom we had classified
as a depression case or control, are summarized in Table 1
and Supplementary Table 2, available as Supplementary
data at IJE online.
Confirmation of association between BMI genetic
instruments and BMI in the UK Biobank
The BMI and favourable adiposity GRS were robustly as-
sociated with BMI, explaining 1.7% and 0.2% of the vari-
ance, respectively. The BMI GRS was also robustly
associated with obesity, explaining 1.5% of the variance.
The BMI GRS was associated with several potential
confounding factors. These included cigarette smoking and
measures of socioeconomic position (including income and
Townsend deprivation index). The associations with
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measures of socioeconomic position disappeared when
adjusting for BMI (Supplementary Table 4, available as
Supplementary data at IJE online), suggesting that BMI
causes changes to socioeconomic position, consistent with
previous Mendelian randomization analyses.38 The associ-
ation between smoking and the BMI GRS weakened but
remained statistically robust. The favourable adiposity
GRS was not associated with any of the potential con-
founding factors tested (Supplementary Table 5, available
as Supplementary data at IJE online).
Higher BMI is associated with depression in the
UK Biobank
Higher BMI was observationally associated with higher odds
of depression (Table 2). A 1-SD (4.7 kg/m2) higher BMI was
associated with a 1.16 (95% CI: 1.15, 1.17) higher odds of
depression. This observational association was stronger in
women than men (women: 1.21, 95% CI: 1.20, 1.23; men:
1.08, 95% CI: 1.07, 1.10, Pdifference<1 x 10
-15; Figure 3).
Obese individuals were at 1.45 (95% CI: 1.41, 1.49)
higher odds of depression than those of normal BMI, with
stronger associations in women (OR: 1.59, 95% CI: 1.53,
1.64) than men (OR: 1.24, 95% CI: 1.19, 1.30).
Mendelian randomization evidence that higher
BMI causes depression
One-sample analysis in the UK Biobank. One-sample
Mendelian randomization tests, using unrelated individu-
als of European ancestry from the UK Biobank, provided
evidence for a causal role of higher BMI in depression. A
genetically determined 1-SD (4.7 kg/m2) higher BMI was
associated with higher odds of depression (OR: 1.18, 95%
CI: 1.09, 1.28; Table 2 and Figure 3). The evidence for a
gender difference in the causal association between BMI
and depression did not reach P<0.05 (Figure 2), although
the point estimates were higher in women than in men (1-
SD higher BMI resulting in 1.23 higher odds of depression,
95% CI: 1.10, 1.38, in women and 1.11, 95% CI: 0.98,
1.26, in men, Pdifference ¼ 0.18).
Similar evidence was observed when genetically instru-
mented obesity was considered. Obese individuals were at
higher odds of depression 1.11, 95% CI: 1.06, 1.16].
Table 2. Associations between higher BMI and depression, using logistic regression and instrumental variable analysis in the
287 503 unrelated UK Biobank individuals
Observationala Geneticb Genetic: Eggerc
Instrument tested Included
individuals
N cases
(controls)
Odds ratio
(95% CI) of
depression per
SD higher BMI
P Odds ratio
(95% CI) of
depression per
SD higher BMI
P Odds ratio
(95% CI) of
depression per
SD higher BMI
P
BMI All individuals 41 397 (246 106) 1.16 (1.15, 1.17) <1x1015 1.18 (1.09, 1.28) 7x105 1.24 (1.02, 1.50) 0.03
1.13 (1.11, 1.14) <1x1015
Men only 15 175 (127 709) 1.08 (1.07, 1.10) <1x1015 1.11 (0.98, 1.26) 0.09 1.23 (0.94, 1.61) 0.13
1.07 (1.05, 1.09) 8x1011
Women only 26 222 (118 397) 1.21 (1.20, 1.23) <1x1015 1.23 (1.10, 1.38) 2x104 1.26 (1.01, 1.56) 0.04
1.18 (1.16, 1.20) <1x1015
Favourable
adiposity
All individuals 41 397 (246 106) 1.16 (1.15, 1.17) <1x1015 1.52 (0.88, 2.61) 0.13 1.10 (0.60, 2.01) 0.77
1.13 (1.11, 1.14) <1x1015
Men only 15 175 (127 709) 1.08 (1.07, 1.10) <1x1015 1.15 (0.47, 2.81) 0.75 0.52 (0.22, 1.23) 0.16
1.07 (1.05, 1.09) 8x1011
Women only 26 222 (118 397) 1.21 (1.20, 1.23) <1x1015 1.79 (0.90, 3.54) 0.09 1.71 (0.78, 3.78) 0.56
1.18 (1.16, 1.20) <1x1015
BMI analyses were repeated with additional variants39 and, although the inclusion of these variants narrowed the confidence intervals, it did not change the
conclusions. Odds of depression (95% CI) in all, men only and women only was 1.12 (95% CI: 1.05, 1.19), 1.11 (95% CI: 1.01, 1.22) and 1.13 (95% CI: 1.04,
1.23), respectively.
aAge- and sex-adjusted associations and the further adjusted models in italics which included a measure of socioeconomic position (the Townsend deprivation
index), smoking, alcohol consumption and physical activity measures (using data from the International Physical Activity Questionnaire) as covariates.
bUses instrumental variable analysis and a two-step procedure for the binary outcomes using the BMI or favourable adiposity GRS. The F-statistic is >4705 in
all individuals, >2466 in men only and >2313 in women only for BMI, and >86.5 in all individuals, >40.6 in men only and >44.6 in women only.
cAlternative genetic approach.33 Note full results for related and unrelated individuals are provided in Supplementary Table 5, available as Supplementary data
at IJE online, for BMI, and Supplementary Table 7, available as Supplementary data at IJE online, for favourable adiposity.
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This was consistent in men (OR: 1.07, 95% CI: 1.00,
1.14]) and women (OR: 1.14, 95% CI: 1.06, 1.21]).
Two-sample analysis. The results from the two-sample
Mendelian randomization in the related Europeans were
consistent with the one-sample results: there was evidence of
a causal association in all individuals and in women only,
but no consistent evidence in men (Figure 4 and Table 2;
Supplementary Table 6, available as Supplementary data at
IJE online). The estimates from the Egger- and Median-MR
analyses were consistent, although confidence intervals were
wider. The Egger method suggested that no pleiotropy was
present (Egger intercept P-value: 0.41 in all individuals).
We obtained very similar estimates when performing sensi-
tivity analyses, including using different definitions of de-
pression and excluding underweight (<18.5 kg/m2)
individuals, those with other health conditions, disease or
parental depression, and including all 76 BMI variants in the
GRS (Supplementary Table 7, available as Supplementary
data at IJE online).
Meta-analysis with results from the Psychiatric Genomics
Consortium. To provide further evidence for or against the
causal role of BMI in depression in all individuals, we next
used the summary statistics from the PGC data, which in-
cluded 45 591 depression cases and 97 647 controls, exclud-
ing the UK Biobank.15 We performed two-sample MR which
provided evidence of a causal role for BMI in major depres-
sive disorder. A 1-SD higher BMI was associated with 1.19
(95% CI: 1.06, 1.34) higher odds of MDD (P¼ 0.005;
Figure 5; and Supplementary Table 5, available as
Supplementary data at IJE online). Similar associations were
noted using methods which are more robust to pleiotropy, al-
though the estimate from MR-Egger crossed the null
(Supplementary Table 6, available as Supplementary data at
IJE online). Meta-analysis of the MR-Egger estimate from
the UK Biobank and the PGC suggested a causal relationship
with a 1-SD higher BMI resulting in 1.25 (95% CI: 1.03,
1.51) higher odds of depression, with no evidence of hetero-
geneity (P¼0.96).
Neuronal and non-neuronal BMI genetic instruments. We
next tested whether the causal association between BMI
and depression was consistent when using genetic instru-
ments for BMI that reflected neuronal versus non-neuronal
pathways. Evidence for a role of neuronal pathways in de-
pression was stronger than for non-neuronal pathways. A
1-SD genetically higher BMI, as defined by neuronal and
non-neuronal GRS, was associated with a 1.26 (95% CI:
1.07, 1.49, P¼ 0.013) and 1.08(95% CI: 0.93, 1.26,
P¼ 0.31) higher odds of depression respectively (Pdifference
¼ 0.17). Similar estimates were obtained with the PGC
data (neuronal: 1.24, 95% CI: 1.06, 1.45, P¼ 0.010; non-
neuronal: 1.14, 95% CI: 0.94, 1.38, P¼ 0.21), and meta-
analyses of the UK Biobank and PGC estimates suggested
no difference between the neuronal and non-neuronal
instruments (Pheterogeneity ¼ 0.14).
Favourable adiposity
Meta-analysis of the inverse-variance weighted Mendelian
randomization estimates from UK Biobank and PGC data
provided tentative evidence of a causal relationship
Figure 3. Forest plot of the observational and genetic associations between a 1-SD higher BMI and the odds of depression. The plots display the ob-
servational association (Observational) and the genetic association using the two-step instrumental variable analysis with the BMI genetic risk score
(Genetic 1-sample).
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between favourable adiposity and depression (OR: 1.26,
95% CI: 1.06, 1.50, P¼ 0.010). The estimates did not
reach P<0.05 in the UK Biobank or PGC studies15 sepa-
rately, but there was no evidence of heterogeneity.
The confidence limits included the causal estimate from
the standard ‘unfavourable adiposity’ BMI instrument
(Table 2; and Supplementary Table 8, available as
Supplementary data at IJE online).
Childhood BMI and depression later in life
We next tested the association of childhood adiposity with
adult depression. We used self-reported perceived body
Figure 4. Plot of the individual BMI variant—BMI associations from the primary GWAS that did not include UK Biobank22 against the BMI variant—de-
pression associations on natural log scale (LN(OH)) from related Europeans in the UK Biobank, in: A) all individuals; B) males only; and C) females
only. The beta regression coefficients for inverse variance weighted (IVW) instrumental analysis (black solid), Egger-MR (black dash),33 median-IV
(grey solid) and the penalized weight median IV (grey dash) are plotted. The Egger intercept P-value is also given on the plots.
Figure 5. Plot of the individual BMI variant—BMI associations from the primary GWAS that did not include UK Biobank22 against the BMI variant—de-
pression associations on natural log scale (LN(OR)) from the PGC GWAS data excluding the UK Biobank. The beta regression coefficients for inverse
variance weighted (IVW) instrumental analysis (black solid), Egger-MR (black dash),33 median-IV (grey solid) and the penalized weight median IV
(grey dash) are plotted.
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size at age 10, and validated these self-report measures by
testing their association with the 73 SNP BMI GRS.
Genetic variants associated with BMI tend to have similar
effects in childhood, suggesting that they act as an instru-
ment for exposure to higher BMI throughout most of life
including childhood.40 In line with this assumption, the
BMI GRS was associated with self-reported size at age 10
in the directions expected (Supplementary Table 9, avail-
able as Supplementary data at IJE online). When compar-
ing with individuals who reported being of average body
size at age 10, individuals who perceived themselves as
plump at age 10 had higher odds of reporting depression
(OR: 1.32, 95% CI: 1.28, 1.37; Supplementary Table 10,
available as Supplementary data at IJE online). Similarly,
individuals who perceived themselves as thinner than aver-
age at age 10 also had higher odds of reporting depression
than individuals who were of average size at age 10 (OR:
1.20, 95% CI: 1.17, 1.23). These associations were
similar in men and women and when adult BMI was
included as a covariate (Supplementary Table 10, available
as Supplementary data at IJE online).
Negative control Mendelian randomization tests
We next selected three variables as negative control tests—
variables that would be very unlikely to be a consequence
of higher BMI and would help control for any residual con-
founding in the data which could affect genetic estimates
in such large sample sizes. These were higher nitrogen di-
oxide pollution levels at home location, urban versus rural
dwelling and less frequent sun protection use in the UK
Biobank, all of which were strongly observationally associ-
ated with higher BMI, most likely as a result of the associa-
tion between higher BMI and poverty and lower
educational attainment (Table 3). We observed some nom-
inal evidence of a causal association between higher BMI
and these variables, but the inclusion of a measure of socio-
economic position, previously shown to be potentially a
consequence of lower BMI, especially in women,38 attenu-
ated the associations (Table 3). Adjusting for socioeco-
nomic position did not alter the causal relationship
between BMI and depression.
Discussion
Using genetic variants as unconfounded proxies for BMI,
our study provides further evidence that higher BMI, and
therefore obesity, leads to higher odds of depression.12–15,41
Several of our sensitivity analyses did not reach formal levels
of statistical significance, but replication by the independent
studies of the PGC provided additional evidence of a causal
effect from higher BMI to higher depression. In addition, we
investigated the causal relationship between higher BMI and
depression in the absence of adverse metabolic effects, inves-
tigated the relationship in men and women individually, and
demonstrated the causal relationship between a binary mea-
sure of obesity and depression.
This study adds to evidence that higher BMI or obesity
causes depression, which has been suggested in previous
observational and genetic studies. However, we have not
ruled a possible bidirectional causal relationship between
higher BMI and depression, as suggested by earlier
Table 3. Associations between higher BMI and three negative control variables, using regression and instrumental variable
analysis and based on the unrelated individuals used in the one sample MR. Our depression variable is included for reference
Observationalb Geneticc Geneticd
Negative control
variable
N Beta or LN(OR)e
representing change
in negative control
variable or
depression per
SD higher BMI
P Beta or LN(OR)e
representing change
in negative control
variable per SD
higher genetically
instrumented BMI
P Beta or LN(OR)e
representing change
in negative control
variable per SD
higher genetically
instrumented BMI
P
Regular sun protection
usea
375 720 0.041 (0.047, 0.036) <1 x 1015 0.052 (0.098, 0.006) 0.028 0.040 (0.087, 0.006) 0.09
Nitrogen dioxide
pollution level
372 791 0.023 (0.020, 0.026) <1 x 1015 0.025 (0.000, 0.050) 0.050 0.006 (0.030, 0.018) 0.63
Rural dwelling 386 131 0.067 (0.076, 0.058) <1 x 1015 0.023 (0.094, 0.048) 0.52 0.006 (0.065, 0.077) 0.88
Depression 41 397 (246 106) 0.150 (0.139, 0.160) <1 x 1015 0.166 (0.084, 0.247) 7 x 105 0.153 (0.07, 0.235) 0.0002
aCoded as never, sometimes, most of the time, always. Analysed using ordinal logistic regression.
bRegression analysis adjusting for age and sex.
cOne-sample instrumental variable analysis with a BMI GRS.
dOne-sample instrumental variable analysis with a BMI GRS and accounting for socioeconomic position using the Townsend deprivation index.
eOn natural log scale, LN(OR).
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systematic reviews of longitudinal studies.11 Further re-
search is required to explore the causal role of depression
on body mass index and obesity. The power for testing the
relationship from depression to BMI is currently limited,
but as more genetic variants are identified for depression
this relationship can be more comprehensively explored.
The availability of individual-level data in the UK
Biobank allowed us to test a number of hypotheses not eas-
ily performed in the context of a GWAS consortium, most
notably the stratification by sex. Our study highlighted po-
tential sex differences in the causal relationships between
BMI and depression which are consistent with observa-
tional data, with stronger associations in women, although
even larger sample sizes or stronger genetic instruments are
needed to confirm this difference. The prevalence of de-
pression is consistently higher in women than men,42 and
in the UK Biobank women were 1.5 times more likely to
report a diagnosis of depression. We have previously
shown, using a Mendelian randomization approach, that
high BMI is causally associated with lower socioeconomic
position in women but with no such evidence in men.38
The combination of these MR results suggests that that the
stigma of high BMI differs between the sexes, and may re-
flect a causal pathway from higher BMI to lower socioeco-
nomic position to higher depression.
A range of factors could link higher BMI to higher odds
of depression, including poorer general health as a result of
high BMI or psychological impacts of obesity. To investigate
this in more detail, we used a genetic instrument for ‘favour-
able adiposity’, where alleles associated with higher BMI are
associated with lower risk of type 2 diabetes, and lower in-
sulin levels. Our analyses provided some tentative evidence
for a causal relationship between favourable adiposity and
depression. This analysis was important in that it suggests a
psychosocial effect of higher BMI as well as, or instead of, a
physiological effect driven by adverse metabolic health.
We also split the BMI GRS into two risk scores, one with
genetic variants acting through neuronal pathways and the
other with genetic variants with non-neuronal functions
and, whereas the association was stronger with neuronal
BMI variants, the confidence intervals for the two genetic
risk scores overlapped. The overlap in the confidence inter-
vals meant that we were not able to state confidently that
there was a difference in the association with depression be-
tween the neuronal and non-neuronal BMI variants.
Most of the genetic variants we used as an instrument for
BMI reflect lifelong differences in BMI, and the association
of the BMI GRS with self-perceived measure of body size at
age 10 years suggested it is a valid measure of BMI in child-
hood. Although this suggests that the BMI instrument is in
part testing the exposure to higher BMI from early child-
hood, we cannot use this current list of genetic variants to
dissect the causal role of lon- term exposure to higher BMI
from more rapid weight gain later in adulthood.
Nevertheless, in observational analyses, individuals who
perceived themselves as plumper than average at age 10 had
higher odds of depression in adulthood than those who
reported average body size at age 10. This association is
consistent with evidence from longitudinal studies suggest-
ing that childhood obesity increases the risk of adulthood
depression.43,44 In our analyses, individuals who reported to
be thinner than average at age 10 were also more likely to
report depression than those individuals reporting normal
body size at age 10, which may help explain the U-shaped
relationship between BMI and depression,5 but could also
be confounded by a range of factors including poverty.
Strengths and limitations
The major strength of this study was the availability of in-
dividual-level data in more than 40 000 depression cases
and 300 000 controls. This allowed us to perform sex-
specific analyses and a number of crucial sensitivity analy-
ses, to provide a comprehensive investigation for the causal
role of BMI, and different aspects of BMI, in MDD. We ac-
knowledge a number of limitations with this study. First,
the UK Biobank participants were born between 1938 and
1971, and the causal associations may not apply to youn-
ger birth cohorts or be generalizable outside the UK.
However, our results were consistent with several other
studies which used data from individuals of different ages
and from different European countries14,15 and PGC data
excluding the UK Biobank. Second, the definition of de-
pression was not gold standard; we used both Hospital
Episode Statistic data and derived self-reported data to
identify depression cases. The experience of some level of
depressive symptoms is part of human experience, and
therefore it is challenging to define clinical depression cases
and controls based on self-reported data. Additionally, the
episodic nature of depression makes it difficult to define in-
cident depression; therefore in this study we looked at any
depression rather than prevalent versus incident. However,
our results were consistent with previous studies and when
only MDD defined from the Hospital Episode Statistics
data in the UK Biobank was used. Third, the BMI GRS
was associated with smoking. However, this association
was minimal in comparison with the strength of the associ-
ation with raw BMI, and unlikely to be altering the results
of this study. Fourth, the BMI GRS we used is likely to be
an instrument to exposure to high BMI from childhood to
adulthood because it is associated with BMI at age 10 as
well as at age 40 to 70 years. The use of a genetic risk score
that captures BMI across a wide age range has advantages
and limitations. The advantage is that we capture high
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BMI for a long period of people’s lives, in contrast to the
cross-sectional association of measured BMI from a single
time point. The limitation is that we cannot separate po-
tential causal effects of high BMI in adulthood from those
in childhood. Fifth, the favourable adiposity GRS only
explains a small percentage of the variance in BMI, but the
large number of depression cases in the UK Biobank and
PGC data meant we had sufficient power to detect a 1.23
higher OR per 1-SD higher BMI, an effect only slightly
higher than that of the observational BMI-depression asso-
ciation. As more favourable adiposity variants are identi-
fied, we will be able to investigate this question in more
detail. Finally, the one-sample approaches in the unrelated
individuals may not fully account for genetic population
differences.45 However, our negative control results, using
sun protection, air pollution and home location, demon-
strated no causal relationships with the BMI genetic risk
score when socioeconomic status was accounted for, and
our analyses in the related sample using the linear mixed
model provided consistent estimates.
In summary, using up to 340 000 participants from the
UK Biobank, we provide evidence that higher BMI, as esti-
mated by genetics is causally related to higher odds of de-
pression, especially in women.
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